CClinicalTrials.gg
CompletedNCT03407573RESULT-NOFUpdated Mar 11, 2020

Restrictive vs Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur

An interventional study of Administration of Red Cell in Anemia, Cardiac Event and Kidney Injury, sponsored by NHS Lothian. Completed at 1 site in United Kingdom. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2020-03-11.

Sponsored by NHS Lothian · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The investigator wishes to see if it is possible to undertake a study comparing blood transfusion at two different levels of anaemia to see which is best for patients. All patients that present to hospital with a broken hip will be able to take part in the study. If they become anaemic during their treatment they will be allocated to either be transfused when their blood count is less that 9 or less than 7. In all patients, we will measure heart damage with a blood test that is very sensitive. The investigator will also collect data on the incidence of heart attacks and other complications.

Read the detailed description

Many frail and elderly patients undergo surgery for hip fractures every year. Many of these patients have other health problems including heart disease and anaemia (low haemoglobin or "low blood count") either from chronic illness, from bleeding at the time of their injury or during subsequent surgery. The vast majority (more than 95%) of these patients will go on to have surgery. This surgery is often high risk. Patients with this type of injury may already be frail, may be in hospital for a long time and will need rehabilitation. Many of them will develop complications, including heart attacks and some will die.

Doctors looking after these patients commonly prescribe a blood transfusion around the time of surgery. These patient often have anaemia before surgery an lose more blood during their operations. A benefit of blood transfusion is that it may increase the amount of oxygen the blood can carry. One of the main reasons that doctors prescribe blood around the time of surgery is to prevent heart attacks, which can occur if the heart doesn't receive enough oxygen. Another possible benefit of blood transfusion is that it may help patients get out of bed more quickly after surgery. This is another important aspect of their recovery.

However, blood transfusions can have side effects such as causing heart failure or increasing infections after surgery. These can delay patient recovery too. Although some research has been done in this area, anaesthetists and surgeons are still unsure of when to prescribe blood transfusions to these patients. In particular, uncertainty about how low the blood count should be before a blood transfusion is ordered. Some doctors prescribe blood when the haemoglobin count is less than 9 and some at a lower level of 7. Current guidelines suggest that prescribing at a lower haemoglobin count is better, but there is research which suggests that this level is too low if the patient has a history of heart disease.

02

Conditions studied

03

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:Adults aged over 50 years Within 48 hours of admission to hospital with fractured Neck of Femur. Exclusion Criteria: Age \<50

  • Refusal of consent of patient (or consultee) Patient for palliative care.
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
200 participants (actual)

Study arms

  • Active comparator
    Restrictive

    Restrictive transfused when Hb at or below 70

    Biological: Administration of Red Cell

  • Active comparator
    Liberal

    Will receive blood transfusion when Hb drops below or equal to 90

    Biological: Administration of Red Cell

Interventions

  • BiologicalAdministration of Red Cell

    Transfusion of red cells dependent on haemoglobin level. Either transfused at haemoglobin of 7 or 9.

05

What researchers measure

Primary outcomes

  1. Myocardial Injury

    Myocardial injury defined as a high sensitivity cardiac Troponin 1 (Troponin) concentration above the upper reference limit \[URL\] OF 16 ng L and 34 ng L in women and men respectively at any time during the study period.

    Time frame: Upto 60 days

Secondary outcomes

  1. Myocardial Infarction

    Myocardial Infarction defined per the universal definition within 30 days of surgery or before hospital discharge, whichever occurs first.

    Time frame: within 30 days of surgery

  2. Mortality

    Mortality (30; 60 days from day of surgery).

    Time frame: upto 60 days following surgery

  3. Diagnosis of Major Adverse Cardiac Events

    New diagnosis of MACE within 30 days of surgery or before hospital discharge, whichever occurs first.

    Time frame: within 30 days or before hospital discharge

  4. Acute Kidney Injury

    New diagnosis of Acute Kidney Injury

    Time frame: within 30 days of surgery or before discharge from hospital whichever occurs first.

  5. Infections

    New diagnosis of Infectious Complications

    Time frame: within 30 days of surgery or before hospital discharge, whichever is first.

  6. Delirium

    New diagnosis of Delirium

    Time frame: within 30 days of surgery or before hospital discharge, whichever occurs first.

Other outcomes

  1. Troponin

    Peak troponin concentration

    Time frame: within 7 days of surgery (ngL )

  2. Troponin -Time

    Area under a Troponin-Time curve

    Time frame: within 7 days of surgery

  3. Red cells transfused

    Number of units red cells transfused

    Time frame: within7 days of surgery and within 30 days of surgery or before hospital discharge, whichever occurs first.

  4. Volume in mls of Red Cells Transfused.

    Volume of red blood cells transfused in mls

    Time frame: within 7 days of surgery and within 30 days of surgery or before hospital discharge, whichever occurs first.

  5. Haemoglobin postoperatively

    Postoperative Hb on postoperative days

    Time frame: days 1,3,5,7 after surgery

  6. Nadir Hb

    Nadir Hb

    Time frame: within 7 days of surgery and within 30 days of surgery or before hospital discharge, whichever occurs first.

  7. Hospital Admission

    Duration of hospital admission (days)

    Time frame: from admission to discharge date from hospital upto 60 days.

  8. Readmission to hospital

    Incidence of unplanned hospital readmission within 60 days

    Time frame: upto 60 days of hospital discharge date

  9. Destination

    Discharge destination (home, other hospital, nursing home, other)

    Time frame: at Discharge from hospital with fractured hip upto 60 days of admission

  10. Health Related Quality of Life

    HRQoL at 60 days (EQ 5D)

    Time frame: at 60 days after surgery

  11. Costs

    Secondary care costs during 60 days post-randomisation in Great British Pound

    Time frame: 60 days post randomisation

06

Study locations

1 site
  • Royal Hospital for Sick Children
    Edinburgh, United Kingdom
07

References and documents

Publications

  • Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg. 2012 Aug;256(2):235-44. doi: 10.1097/SLA.0b013e31825b35d5. PubMed 22791100 ↗
  • Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg. 2015 Oct;102(11):1314-24. doi: 10.1002/bjs.9861. PubMed 26349842 ↗
  • Davenport DL, Bowe EA, Henderson WG, Khuri SF, Mentzer RM Jr. National Surgical Quality Improvement Program (NSQIP) risk factors can be used to validate American Society of Anesthesiologists Physical Status Classification (ASA PS) levels. Ann Surg. 2006 May;243(5):636-41; discussion 641-4. doi: 10.1097/01.sla.0000216508.95556.cc. PubMed 16632998 ↗
  • Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ. 2015 Mar 24;350:h1354. doi: 10.1136/bmj.h1354. PubMed 25805204 ↗
  • Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5. PubMed 34932836 ↗
  • Gillies MA, Ghaffar S, Moppett IK, Docherty AB, Clarke S, Rea N, Stephen J, Keerie C, Ray DC, White TO, MacLullich AMJ, Mills NM, Rowley MR, Murthy K, Pearse RM, Stanworth SJ, Walsh TS. A restrictive versus liberal transfusion strategy to prevent myocardial injury in patients undergoing surgery for fractured neck of femur: a feasibility randomised trial (RESULT-NOF). Br J Anaesth. 2021 Jan;126(1):77-86. doi: 10.1016/j.bja.2020.06.048. Epub 2020 Jul 21. PubMed 32703548 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03407573
Lead sponsor
NHS Lothian
Responsible party
Sponsor
First posted
Jan 23, 2018
Start date
Oct 1, 2017
Primary completion
Mar 1, 2019
Completion
Jun 1, 2019
Last update
Mar 11, 2020

Study contacts

Dr.Mike Gillies
principal investigator · Associate Medical Director

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion